Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Oryzon Genomics SA ( (ES:ORY) ) just unveiled an announcement.
Oryzon Genomics, S.A. has announced that its Board of Directors will convene an Extraordinary General Meeting of Shareholders. The meeting is scheduled for February 28, 2025, in Madrid, with provisions for a second meeting if the initial quorum is not met. This meeting is significant for stakeholders as it will address important resolutions and provide insights into the company’s strategic directions.
More about Oryzon Genomics SA
YTD Price Performance: -2.93%
Average Trading Volume: 4,869
Technical Sentiment Consensus Rating: Buy
Current Market Cap: €93.64M
Learn more about ORY stock on TipRanks’ Stock Analysis page.
